Matches in Wikidata for { <http://www.wikidata.org/entity/Q58023799> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q58023799 description "im März 2011 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58023799 description "wetenschappelijk artikel" @default.
- Q58023799 description "наукова стаття, опублікована в березні 2011" @default.
- Q58023799 name "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 name "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 type Item @default.
- Q58023799 label "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 label "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 prefLabel "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 prefLabel "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 P1433 Q58023799-13BCD391-AA07-48B4-B6D6-808DFCED0EE9 @default.
- Q58023799 P1476 Q58023799-DF5EA93E-EFD8-4A05-BD54-B975E351BFA1 @default.
- Q58023799 P2093 Q58023799-136B3501-D1DF-4083-8B7E-39B013B474B5 @default.
- Q58023799 P2093 Q58023799-5161CB39-1CA2-4ED9-961D-2437FE58C3BD @default.
- Q58023799 P2093 Q58023799-B697B754-7F26-4FDB-BF8E-F5A569A5FE47 @default.
- Q58023799 P2860 Q58023799-4ECE70AB-D344-4F2D-BA9F-2573CBEBDFE8 @default.
- Q58023799 P2860 Q58023799-6769E5EE-0A11-413B-9A3C-F97AD6BB732D @default.
- Q58023799 P2860 Q58023799-99362F20-3EFE-4A7C-839D-C91888990651 @default.
- Q58023799 P2860 Q58023799-ECD2206F-F16F-4FEF-88B7-5980E6E42236 @default.
- Q58023799 P2860 Q58023799-FFF720FF-6D4D-449C-B711-10F414F5D6E0 @default.
- Q58023799 P2888 Q58023799-945DDEE5-38A9-44AC-8B6C-5B6DD94C9826 @default.
- Q58023799 P304 Q58023799-15B3B84A-CB50-43F8-989F-CB899453066A @default.
- Q58023799 P31 Q58023799-C5200F74-0CCB-441A-92FE-A6BF112B20A3 @default.
- Q58023799 P356 Q58023799-141784C9-D761-4679-92DC-34CCFD4CE80A @default.
- Q58023799 P407 Q58023799-AE4A1BD1-AD0E-4D0B-ADD0-09BF7858E49A @default.
- Q58023799 P433 Q58023799-D0A365AB-819C-4003-9D9C-12003016C88D @default.
- Q58023799 P478 Q58023799-866AE49E-DFCB-47EC-85FC-E6AD0FFB71B5 @default.
- Q58023799 P50 Q58023799-F516B30D-ABA9-43DA-ADF0-03C6DF35B569 @default.
- Q58023799 P577 Q58023799-321AC29D-38A1-4D01-AD08-4E7AC0699C14 @default.
- Q58023799 P698 Q58023799-89697B05-C5A6-4148-AA92-6D85103AB00F @default.
- Q58023799 P356 BMT.2011.70 @default.
- Q58023799 P698 21441956 @default.
- Q58023799 P1433 Q4941523 @default.
- Q58023799 P1476 "Outcome of patients with CML after SCT in the era of tyrosine kinase inhibitors" @default.
- Q58023799 P2093 "A Gratwohl" @default.
- Q58023799 P2093 "R Hehlmann" @default.
- Q58023799 P2093 "S Saußele" @default.
- Q58023799 P2860 Q33632220 @default.
- Q58023799 P2860 Q37163550 @default.
- Q58023799 P2860 Q37763493 @default.
- Q58023799 P2860 Q43228834 @default.
- Q58023799 P2860 Q58023956 @default.
- Q58023799 P2888 bmt.2011.70 @default.
- Q58023799 P304 "304-304" @default.
- Q58023799 P31 Q13442814 @default.
- Q58023799 P356 "10.1038/BMT.2011.70" @default.
- Q58023799 P407 Q1860 @default.
- Q58023799 P433 "2" @default.
- Q58023799 P478 "47" @default.
- Q58023799 P50 Q37829812 @default.
- Q58023799 P577 "2011-03-28T00:00:00Z" @default.
- Q58023799 P698 "21441956" @default.